Announced Tue, 7 Jul · 15:20 IST
Quarterly compliance certificate submitted to BSE for Apr-Jun 2026
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.3%1-day move
₹0.30
prior close
₹0.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.3———-3.3-3.3-3.3-3.3+0.0+6.7————
Up moveDown movePending
AI summary
Biogen Pharmachem Industries submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ending 30 June 2026. The Registrar and Share Transfer Agent confirms that no physical share certificates were received for dematerialisation during the quarter. This is a standard regulatory filing with no material business impact.
Likely market impact
Routine compliance filing. No impact on shareholders or stock price.